Global Controlled Release Drug Delivery Market

Controlled Release Drug Delivery Comprehensive Study by Type (Inhalers, Injectable, Others), Application (Hospitals & Clinics, Research Organisations), Route of Administration (Oral, Transdermal, Others), Technology (Micro Encapsulation, Polymeric Controlled, Targeted Drug Delivery) Players and Region - Global Market Outlook to 2027

Controlled Release Drug Delivery Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Controlled Release Drug Delivery
A controlled drug delivery system is used to release dosages in particular concentration directly into desired zone. It is especially provides correct & efficient release of therapeutics in required period of time. This allows maximizing the efficacy of the therapeutic. In addition, it reduces the side effects like infection and others. Targeted therapeutics are administrated at the particular site where it is need to be deliver. Numerous companies are evolving in providing controlled drug delivery to be administered by various routes. This it is mostly prefer over the conventional routes mainly focusing on the respiratory tract. Several unique feature like efficiency in delivering Low amount of administered doses, less gastrointestinal side effects associated with it, it also improves patient acceptance & compliance. Increasing R&D expenditure by pharmaceutical development companies are creating growth opportunities for market. This companies are further developing efficient therapy for non-communicable diseases such as cancer, diabetes and chronic is anticipated to boost market growth.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The market of Controlled Drug Delivery System is expected to grow with rising demand for efficient release of drug via different route of administration. There are various companies are operating in the market to provides excellent controlled drug delivery system for hospitals & clinics. Major players in the industry are gaining attention from the market and other players are entering to capture market growth opportunities. The market leaders are investing on organic and non-organic strategic growth initiatives to become dominant in this industry. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Johnson and Johnson (United States), Merck and Co., Inc (United States), Pfizer, Inc. (United States), Corium International, Inc. (Sweden), Aradigm Corporation (Finland), Aspen Technology Inc (United States), Penwest Pharmaceuticals (United States), Orbis Biosciences, Inc (United States), Lubrizol Life Science (United States), Colorcon (United States), IRISYS, LLC (United States), Elkem ASA (United States) and AstraZeneca (United Kingdom) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Controlled Release Drug Delivery market by Type (Inhalers, Injectable and Others), Application (Hospitals & Clinics and Research Organisations) and Region.



On the basis of geography, the market of Controlled Release Drug Delivery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Route of Administration, the sub-segment i.e. Oral will boost the Controlled Release Drug Delivery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Micro Encapsulation will boost the Controlled Release Drug Delivery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Pharmaceutical Industry Is Leading Towards Providing Cost Efficient Drug Delivery Systems

Market Growth Drivers:
Increasing Infrastructure of Pharmaceutical Industry Particularly For Controlled Systems Manufacturing, Raised Inclination towards Preferring Control System Patterns over Traditional Drug Delivery Systems and Growing Popularity of Customized Controlled Drug Delivery Systems is driving the Demand of Controlled Drug Delivery System

Challenges:
Less Efficiency to Deliver High Molecular Weight Compound

Restraints:
Stringent Government Regulations and Risk Associated With Toxicity during Drug Administrating

Opportunities:
Technological Advancements with Nanomedicine and Nano Delivery Systems Has Created Ample Opportunities




Key Target Audience
Controlled Drug Delivery System Manufacturers/Suppliers/Distributor, Raw Material Suppliers, New Entrants/Investors, Strategic Business Planners, Government Regulatory and End Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Inhalers
  • Injectable
  • Others
By Application
  • Hospitals & Clinics
  • Research Organisations
By Route of Administration
  • Oral
  • Transdermal
  • Others

By Technology
  • Micro Encapsulation
  • Polymeric Controlled
  • Targeted Drug Delivery

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Infrastructure of Pharmaceutical Industry Particularly For Controlled Systems Manufacturing
      • 3.2.2. Raised Inclination towards Preferring Control System Patterns over Traditional Drug Delivery Systems
      • 3.2.3. Growing Popularity of Customized Controlled Drug Delivery Systems is driving the Demand of Controlled Drug Delivery System
    • 3.3. Market Challenges
      • 3.3.1. Less Efficiency to Deliver High Molecular Weight Compound
    • 3.4. Market Trends
      • 3.4.1. Pharmaceutical Industry Is Leading Towards Providing Cost Efficient Drug Delivery Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Controlled Release Drug Delivery, by Type, Application, Route of Administration, Technology and Region (value and volume ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Controlled Release Drug Delivery (Value)
      • 5.2.1. Global Controlled Release Drug Delivery by: Type (Value)
        • 5.2.1.1. Inhalers
        • 5.2.1.2. Injectable
        • 5.2.1.3. Others
      • 5.2.2. Global Controlled Release Drug Delivery by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Research Organisations
      • 5.2.3. Global Controlled Release Drug Delivery by: Route of Administration (Value)
        • 5.2.3.1. Oral
        • 5.2.3.2. Transdermal
        • 5.2.3.3. Others
      • 5.2.4. Global Controlled Release Drug Delivery by: Technology (Value)
        • 5.2.4.1. Micro Encapsulation
        • 5.2.4.2. Polymeric Controlled
        • 5.2.4.3. Targeted Drug Delivery
      • 5.2.5. Global Controlled Release Drug Delivery Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Controlled Release Drug Delivery (Volume)
      • 5.3.1. Global Controlled Release Drug Delivery by: Type (Volume)
        • 5.3.1.1. Inhalers
        • 5.3.1.2. Injectable
        • 5.3.1.3. Others
      • 5.3.2. Global Controlled Release Drug Delivery by: Application (Volume)
        • 5.3.2.1. Hospitals & Clinics
        • 5.3.2.2. Research Organisations
      • 5.3.3. Global Controlled Release Drug Delivery by: Route of Administration (Volume)
        • 5.3.3.1. Oral
        • 5.3.3.2. Transdermal
        • 5.3.3.3. Others
      • 5.3.4. Global Controlled Release Drug Delivery by: Technology (Volume)
        • 5.3.4.1. Micro Encapsulation
        • 5.3.4.2. Polymeric Controlled
        • 5.3.4.3. Targeted Drug Delivery
      • 5.3.5. Global Controlled Release Drug Delivery Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
  • 6. Controlled Release Drug Delivery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson and Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck and Co., Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Corium International, Inc. (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aradigm Corporation (Finland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Aspen Technology Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Penwest Pharmaceuticals (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Orbis Biosciences, Inc (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lubrizol Life Science (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Colorcon (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. IRISYS, LLC (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Elkem ASA (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. AstraZeneca (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Controlled Release Drug Delivery Sale, by Type, Application, Route of Administration, Technology and Region (value and volume ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Controlled Release Drug Delivery (Value)
      • 7.2.1. Global Controlled Release Drug Delivery by: Type (Value)
        • 7.2.1.1. Inhalers
        • 7.2.1.2. Injectable
        • 7.2.1.3. Others
      • 7.2.2. Global Controlled Release Drug Delivery by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Research Organisations
      • 7.2.3. Global Controlled Release Drug Delivery by: Route of Administration (Value)
        • 7.2.3.1. Oral
        • 7.2.3.2. Transdermal
        • 7.2.3.3. Others
      • 7.2.4. Global Controlled Release Drug Delivery by: Technology (Value)
        • 7.2.4.1. Micro Encapsulation
        • 7.2.4.2. Polymeric Controlled
        • 7.2.4.3. Targeted Drug Delivery
      • 7.2.5. Global Controlled Release Drug Delivery Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Controlled Release Drug Delivery (Volume)
      • 7.3.1. Global Controlled Release Drug Delivery by: Type (Volume)
        • 7.3.1.1. Inhalers
        • 7.3.1.2. Injectable
        • 7.3.1.3. Others
      • 7.3.2. Global Controlled Release Drug Delivery by: Application (Volume)
        • 7.3.2.1. Hospitals & Clinics
        • 7.3.2.2. Research Organisations
      • 7.3.3. Global Controlled Release Drug Delivery by: Route of Administration (Volume)
        • 7.3.3.1. Oral
        • 7.3.3.2. Transdermal
        • 7.3.3.3. Others
      • 7.3.4. Global Controlled Release Drug Delivery by: Technology (Volume)
        • 7.3.4.1. Micro Encapsulation
        • 7.3.4.2. Polymeric Controlled
        • 7.3.4.3. Targeted Drug Delivery
      • 7.3.5. Global Controlled Release Drug Delivery Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Controlled Release Drug Delivery: by Type(USD Million)
  • Table 2. Controlled Release Drug Delivery Inhalers , by Region USD Million (2016-2021)
  • Table 3. Controlled Release Drug Delivery Injectable , by Region USD Million (2016-2021)
  • Table 4. Controlled Release Drug Delivery Others , by Region USD Million (2016-2021)
  • Table 5. Controlled Release Drug Delivery: by Application(USD Million)
  • Table 6. Controlled Release Drug Delivery Hospitals & Clinics , by Region USD Million (2016-2021)
  • Table 7. Controlled Release Drug Delivery Research Organisations , by Region USD Million (2016-2021)
  • Table 8. Controlled Release Drug Delivery: by Route of Administration(USD Million)
  • Table 9. Controlled Release Drug Delivery Oral , by Region USD Million (2016-2021)
  • Table 10. Controlled Release Drug Delivery Transdermal , by Region USD Million (2016-2021)
  • Table 11. Controlled Release Drug Delivery Others , by Region USD Million (2016-2021)
  • Table 12. Controlled Release Drug Delivery: by Technology(USD Million)
  • Table 13. Controlled Release Drug Delivery Micro Encapsulation , by Region USD Million (2016-2021)
  • Table 14. Controlled Release Drug Delivery Polymeric Controlled , by Region USD Million (2016-2021)
  • Table 15. Controlled Release Drug Delivery Targeted Drug Delivery , by Region USD Million (2016-2021)
  • Table 16. South America Controlled Release Drug Delivery, by Country USD Million (2016-2021)
  • Table 17. South America Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 18. South America Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 19. South America Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 20. South America Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 21. Brazil Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 22. Brazil Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 23. Brazil Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 24. Brazil Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 25. Argentina Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 26. Argentina Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 27. Argentina Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 28. Argentina Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 29. Rest of South America Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 31. Rest of South America Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 32. Rest of South America Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 33. Asia Pacific Controlled Release Drug Delivery, by Country USD Million (2016-2021)
  • Table 34. Asia Pacific Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 35. Asia Pacific Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 36. Asia Pacific Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 37. Asia Pacific Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 38. China Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 39. China Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 40. China Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 41. China Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 42. Japan Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 43. Japan Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 44. Japan Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 45. Japan Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 46. India Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 47. India Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 48. India Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 49. India Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 50. South Korea Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 51. South Korea Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 52. South Korea Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 53. South Korea Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 54. Taiwan Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 55. Taiwan Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 56. Taiwan Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 57. Taiwan Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 58. Australia Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 59. Australia Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 60. Australia Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 61. Australia Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 66. Europe Controlled Release Drug Delivery, by Country USD Million (2016-2021)
  • Table 67. Europe Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 68. Europe Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 69. Europe Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 70. Europe Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 71. Germany Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 72. Germany Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 73. Germany Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 74. Germany Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 75. France Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 76. France Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 77. France Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 78. France Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 79. Italy Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 80. Italy Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 81. Italy Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 82. Italy Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 83. United Kingdom Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 84. United Kingdom Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 85. United Kingdom Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 86. United Kingdom Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 87. Netherlands Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 88. Netherlands Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 89. Netherlands Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 90. Netherlands Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 91. Rest of Europe Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 92. Rest of Europe Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 93. Rest of Europe Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 94. Rest of Europe Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 95. MEA Controlled Release Drug Delivery, by Country USD Million (2016-2021)
  • Table 96. MEA Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 97. MEA Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 98. MEA Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 99. MEA Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 100. Middle East Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 101. Middle East Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 102. Middle East Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 103. Middle East Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 104. Africa Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 105. Africa Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 106. Africa Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 107. Africa Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 108. North America Controlled Release Drug Delivery, by Country USD Million (2016-2021)
  • Table 109. North America Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 110. North America Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 111. North America Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 112. North America Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 113. United States Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 114. United States Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 115. United States Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 116. United States Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 117. Canada Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 118. Canada Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 119. Canada Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 120. Canada Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 121. Mexico Controlled Release Drug Delivery, by Type USD Million (2016-2021)
  • Table 122. Mexico Controlled Release Drug Delivery, by Application USD Million (2016-2021)
  • Table 123. Mexico Controlled Release Drug Delivery, by Route of Administration USD Million (2016-2021)
  • Table 124. Mexico Controlled Release Drug Delivery, by Technology USD Million (2016-2021)
  • Table 125. Controlled Release Drug Delivery Sales: by Type(K Tons)
  • Table 126. Controlled Release Drug Delivery Sales Inhalers , by Region K Tons (2016-2021)
  • Table 127. Controlled Release Drug Delivery Sales Injectable , by Region K Tons (2016-2021)
  • Table 128. Controlled Release Drug Delivery Sales Others , by Region K Tons (2016-2021)
  • Table 129. Controlled Release Drug Delivery Sales: by Application(K Tons)
  • Table 130. Controlled Release Drug Delivery Sales Hospitals & Clinics , by Region K Tons (2016-2021)
  • Table 131. Controlled Release Drug Delivery Sales Research Organisations , by Region K Tons (2016-2021)
  • Table 132. Controlled Release Drug Delivery Sales: by Route of Administration(K Tons)
  • Table 133. Controlled Release Drug Delivery Sales Oral , by Region K Tons (2016-2021)
  • Table 134. Controlled Release Drug Delivery Sales Transdermal , by Region K Tons (2016-2021)
  • Table 135. Controlled Release Drug Delivery Sales Others , by Region K Tons (2016-2021)
  • Table 136. Controlled Release Drug Delivery Sales: by Technology(K Tons)
  • Table 137. Controlled Release Drug Delivery Sales Micro Encapsulation , by Region K Tons (2016-2021)
  • Table 138. Controlled Release Drug Delivery Sales Polymeric Controlled , by Region K Tons (2016-2021)
  • Table 139. Controlled Release Drug Delivery Sales Targeted Drug Delivery , by Region K Tons (2016-2021)
  • Table 140. South America Controlled Release Drug Delivery Sales, by Country K Tons (2016-2021)
  • Table 141. South America Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 142. South America Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 143. South America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 144. South America Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 145. Brazil Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 146. Brazil Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 147. Brazil Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 148. Brazil Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 149. Argentina Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 150. Argentina Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 151. Argentina Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 152. Argentina Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 153. Rest of South America Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 154. Rest of South America Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 155. Rest of South America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 156. Rest of South America Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 157. Asia Pacific Controlled Release Drug Delivery Sales, by Country K Tons (2016-2021)
  • Table 158. Asia Pacific Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 159. Asia Pacific Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 160. Asia Pacific Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 161. Asia Pacific Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 162. China Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 163. China Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 164. China Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 165. China Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 166. Japan Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 167. Japan Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 168. Japan Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 169. Japan Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 170. India Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 171. India Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 172. India Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 173. India Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 174. South Korea Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 175. South Korea Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 176. South Korea Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 177. South Korea Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 178. Taiwan Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 179. Taiwan Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 180. Taiwan Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 181. Taiwan Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 182. Australia Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 183. Australia Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 184. Australia Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 185. Australia Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 186. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 187. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 188. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 189. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 190. Europe Controlled Release Drug Delivery Sales, by Country K Tons (2016-2021)
  • Table 191. Europe Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 192. Europe Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 193. Europe Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 194. Europe Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 195. Germany Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 196. Germany Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 197. Germany Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 198. Germany Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 199. France Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 200. France Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 201. France Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 202. France Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 203. Italy Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 204. Italy Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 205. Italy Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 206. Italy Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 207. United Kingdom Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 208. United Kingdom Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 209. United Kingdom Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 210. United Kingdom Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 211. Netherlands Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 212. Netherlands Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 213. Netherlands Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 214. Netherlands Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 215. Rest of Europe Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 216. Rest of Europe Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 217. Rest of Europe Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 218. Rest of Europe Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 219. MEA Controlled Release Drug Delivery Sales, by Country K Tons (2016-2021)
  • Table 220. MEA Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 221. MEA Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 222. MEA Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 223. MEA Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 224. Middle East Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 225. Middle East Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 226. Middle East Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 227. Middle East Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 228. Africa Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 229. Africa Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 230. Africa Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 231. Africa Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 232. North America Controlled Release Drug Delivery Sales, by Country K Tons (2016-2021)
  • Table 233. North America Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 234. North America Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 235. North America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 236. North America Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 237. United States Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 238. United States Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 239. United States Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 240. United States Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 241. Canada Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 242. Canada Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 243. Canada Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 244. Canada Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 245. Mexico Controlled Release Drug Delivery Sales, by Type K Tons (2016-2021)
  • Table 246. Mexico Controlled Release Drug Delivery Sales, by Application K Tons (2016-2021)
  • Table 247. Mexico Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2016-2021)
  • Table 248. Mexico Controlled Release Drug Delivery Sales, by Technology K Tons (2016-2021)
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Controlled Release Drug Delivery: by Type(USD Million)
  • Table 263. Controlled Release Drug Delivery Inhalers , by Region USD Million (2022-2027)
  • Table 264. Controlled Release Drug Delivery Injectable , by Region USD Million (2022-2027)
  • Table 265. Controlled Release Drug Delivery Others , by Region USD Million (2022-2027)
  • Table 266. Controlled Release Drug Delivery: by Application(USD Million)
  • Table 267. Controlled Release Drug Delivery Hospitals & Clinics , by Region USD Million (2022-2027)
  • Table 268. Controlled Release Drug Delivery Research Organisations , by Region USD Million (2022-2027)
  • Table 269. Controlled Release Drug Delivery: by Route of Administration(USD Million)
  • Table 270. Controlled Release Drug Delivery Oral , by Region USD Million (2022-2027)
  • Table 271. Controlled Release Drug Delivery Transdermal , by Region USD Million (2022-2027)
  • Table 272. Controlled Release Drug Delivery Others , by Region USD Million (2022-2027)
  • Table 273. Controlled Release Drug Delivery: by Technology(USD Million)
  • Table 274. Controlled Release Drug Delivery Micro Encapsulation , by Region USD Million (2022-2027)
  • Table 275. Controlled Release Drug Delivery Polymeric Controlled , by Region USD Million (2022-2027)
  • Table 276. Controlled Release Drug Delivery Targeted Drug Delivery , by Region USD Million (2022-2027)
  • Table 277. South America Controlled Release Drug Delivery, by Country USD Million (2022-2027)
  • Table 278. South America Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 279. South America Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 280. South America Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 281. South America Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 282. Brazil Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 283. Brazil Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 284. Brazil Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 285. Brazil Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 286. Argentina Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 287. Argentina Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 288. Argentina Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 289. Argentina Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 290. Rest of South America Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 291. Rest of South America Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 292. Rest of South America Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 293. Rest of South America Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 294. Asia Pacific Controlled Release Drug Delivery, by Country USD Million (2022-2027)
  • Table 295. Asia Pacific Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 296. Asia Pacific Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 297. Asia Pacific Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 298. Asia Pacific Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 299. China Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 300. China Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 301. China Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 302. China Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 303. Japan Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 304. Japan Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 305. Japan Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 306. Japan Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 307. India Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 308. India Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 309. India Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 310. India Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 311. South Korea Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 312. South Korea Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 313. South Korea Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 314. South Korea Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 315. Taiwan Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 316. Taiwan Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 317. Taiwan Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 318. Taiwan Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 319. Australia Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 320. Australia Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 321. Australia Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 322. Australia Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 323. Rest of Asia-Pacific Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 324. Rest of Asia-Pacific Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 325. Rest of Asia-Pacific Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 326. Rest of Asia-Pacific Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 327. Europe Controlled Release Drug Delivery, by Country USD Million (2022-2027)
  • Table 328. Europe Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 329. Europe Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 330. Europe Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 331. Europe Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 332. Germany Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 333. Germany Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 334. Germany Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 335. Germany Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 336. France Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 337. France Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 338. France Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 339. France Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 340. Italy Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 341. Italy Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 342. Italy Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 343. Italy Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 344. United Kingdom Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 345. United Kingdom Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 346. United Kingdom Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 347. United Kingdom Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 348. Netherlands Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 349. Netherlands Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 350. Netherlands Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 351. Netherlands Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 352. Rest of Europe Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 353. Rest of Europe Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 354. Rest of Europe Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 355. Rest of Europe Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 356. MEA Controlled Release Drug Delivery, by Country USD Million (2022-2027)
  • Table 357. MEA Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 358. MEA Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 359. MEA Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 360. MEA Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 361. Middle East Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 362. Middle East Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 363. Middle East Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 364. Middle East Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 365. Africa Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 366. Africa Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 367. Africa Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 368. Africa Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 369. North America Controlled Release Drug Delivery, by Country USD Million (2022-2027)
  • Table 370. North America Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 371. North America Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 372. North America Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 373. North America Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 374. United States Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 375. United States Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 376. United States Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 377. United States Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 378. Canada Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 379. Canada Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 380. Canada Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 381. Canada Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 382. Mexico Controlled Release Drug Delivery, by Type USD Million (2022-2027)
  • Table 383. Mexico Controlled Release Drug Delivery, by Application USD Million (2022-2027)
  • Table 384. Mexico Controlled Release Drug Delivery, by Route of Administration USD Million (2022-2027)
  • Table 385. Mexico Controlled Release Drug Delivery, by Technology USD Million (2022-2027)
  • Table 386. Controlled Release Drug Delivery Sales: by Type(K Tons)
  • Table 387. Controlled Release Drug Delivery Sales Inhalers , by Region K Tons (2022-2027)
  • Table 388. Controlled Release Drug Delivery Sales Injectable , by Region K Tons (2022-2027)
  • Table 389. Controlled Release Drug Delivery Sales Others , by Region K Tons (2022-2027)
  • Table 390. Controlled Release Drug Delivery Sales: by Application(K Tons)
  • Table 391. Controlled Release Drug Delivery Sales Hospitals & Clinics , by Region K Tons (2022-2027)
  • Table 392. Controlled Release Drug Delivery Sales Research Organisations , by Region K Tons (2022-2027)
  • Table 393. Controlled Release Drug Delivery Sales: by Route of Administration(K Tons)
  • Table 394. Controlled Release Drug Delivery Sales Oral , by Region K Tons (2022-2027)
  • Table 395. Controlled Release Drug Delivery Sales Transdermal , by Region K Tons (2022-2027)
  • Table 396. Controlled Release Drug Delivery Sales Others , by Region K Tons (2022-2027)
  • Table 397. Controlled Release Drug Delivery Sales: by Technology(K Tons)
  • Table 398. Controlled Release Drug Delivery Sales Micro Encapsulation , by Region K Tons (2022-2027)
  • Table 399. Controlled Release Drug Delivery Sales Polymeric Controlled , by Region K Tons (2022-2027)
  • Table 400. Controlled Release Drug Delivery Sales Targeted Drug Delivery , by Region K Tons (2022-2027)
  • Table 401. South America Controlled Release Drug Delivery Sales, by Country K Tons (2022-2027)
  • Table 402. South America Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 403. South America Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 404. South America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 405. South America Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 406. Brazil Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 407. Brazil Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 408. Brazil Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 409. Brazil Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 410. Argentina Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 411. Argentina Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 412. Argentina Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 413. Argentina Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 414. Rest of South America Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 415. Rest of South America Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 416. Rest of South America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 417. Rest of South America Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 418. Asia Pacific Controlled Release Drug Delivery Sales, by Country K Tons (2022-2027)
  • Table 419. Asia Pacific Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 420. Asia Pacific Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 421. Asia Pacific Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 422. Asia Pacific Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 423. China Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 424. China Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 425. China Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 426. China Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 427. Japan Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 428. Japan Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 429. Japan Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 430. Japan Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 431. India Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 432. India Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 433. India Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 434. India Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 435. South Korea Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 436. South Korea Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 437. South Korea Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 438. South Korea Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 439. Taiwan Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 440. Taiwan Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 441. Taiwan Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 442. Taiwan Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 443. Australia Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 444. Australia Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 445. Australia Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 446. Australia Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 447. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 448. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 449. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 450. Rest of Asia-Pacific Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 451. Europe Controlled Release Drug Delivery Sales, by Country K Tons (2022-2027)
  • Table 452. Europe Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 453. Europe Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 454. Europe Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 455. Europe Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 456. Germany Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 457. Germany Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 458. Germany Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 459. Germany Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 460. France Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 461. France Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 462. France Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 463. France Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 464. Italy Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 465. Italy Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 466. Italy Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 467. Italy Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 468. United Kingdom Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 469. United Kingdom Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 470. United Kingdom Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 471. United Kingdom Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 472. Netherlands Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 473. Netherlands Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 474. Netherlands Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 475. Netherlands Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 476. Rest of Europe Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 477. Rest of Europe Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 478. Rest of Europe Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 479. Rest of Europe Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 480. MEA Controlled Release Drug Delivery Sales, by Country K Tons (2022-2027)
  • Table 481. MEA Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 482. MEA Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 483. MEA Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 484. MEA Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 485. Middle East Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 486. Middle East Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 487. Middle East Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 488. Middle East Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 489. Africa Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 490. Africa Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 491. Africa Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 492. Africa Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 493. North America Controlled Release Drug Delivery Sales, by Country K Tons (2022-2027)
  • Table 494. North America Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 495. North America Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 496. North America Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 497. North America Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 498. United States Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 499. United States Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 500. United States Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 501. United States Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 502. Canada Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 503. Canada Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 504. Canada Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 505. Canada Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 506. Mexico Controlled Release Drug Delivery Sales, by Type K Tons (2022-2027)
  • Table 507. Mexico Controlled Release Drug Delivery Sales, by Application K Tons (2022-2027)
  • Table 508. Mexico Controlled Release Drug Delivery Sales, by Route of Administration K Tons (2022-2027)
  • Table 509. Mexico Controlled Release Drug Delivery Sales, by Technology K Tons (2022-2027)
  • Table 510. Research Programs/Design for This Report
  • Table 511. Key Data Information from Secondary Sources
  • Table 512. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Controlled Release Drug Delivery: by Type USD Million (2016-2021)
  • Figure 5. Global Controlled Release Drug Delivery: by Application USD Million (2016-2021)
  • Figure 6. Global Controlled Release Drug Delivery: by Route of Administration USD Million (2016-2021)
  • Figure 7. Global Controlled Release Drug Delivery: by Technology USD Million (2016-2021)
  • Figure 8. South America Controlled Release Drug Delivery Share (%), by Country
  • Figure 9. Asia Pacific Controlled Release Drug Delivery Share (%), by Country
  • Figure 10. Europe Controlled Release Drug Delivery Share (%), by Country
  • Figure 11. MEA Controlled Release Drug Delivery Share (%), by Country
  • Figure 12. North America Controlled Release Drug Delivery Share (%), by Country
  • Figure 13. Global Controlled Release Drug Delivery: by Type K Tons (2016-2021)
  • Figure 14. Global Controlled Release Drug Delivery: by Application K Tons (2016-2021)
  • Figure 15. Global Controlled Release Drug Delivery: by Route of Administration K Tons (2016-2021)
  • Figure 16. Global Controlled Release Drug Delivery: by Technology K Tons (2016-2021)
  • Figure 17. South America Controlled Release Drug Delivery Share (%), by Country
  • Figure 18. Asia Pacific Controlled Release Drug Delivery Share (%), by Country
  • Figure 19. Europe Controlled Release Drug Delivery Share (%), by Country
  • Figure 20. MEA Controlled Release Drug Delivery Share (%), by Country
  • Figure 21. North America Controlled Release Drug Delivery Share (%), by Country
  • Figure 22. Global Controlled Release Drug Delivery share by Players 2021 (%)
  • Figure 23. Global Controlled Release Drug Delivery share by Players (Top 3) 2021(%)
  • Figure 24. Global Controlled Release Drug Delivery share by Players (Top 5) 2021(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 27. Johnson and Johnson (United States) Revenue: by Geography 2021
  • Figure 28. Merck and Co., Inc (United States) Revenue, Net Income and Gross profit
  • Figure 29. Merck and Co., Inc (United States) Revenue: by Geography 2021
  • Figure 30. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Pfizer, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Corium International, Inc. (Sweden) Revenue, Net Income and Gross profit
  • Figure 33. Corium International, Inc. (Sweden) Revenue: by Geography 2021
  • Figure 34. Aradigm Corporation (Finland) Revenue, Net Income and Gross profit
  • Figure 35. Aradigm Corporation (Finland) Revenue: by Geography 2021
  • Figure 36. Aspen Technology Inc (United States) Revenue, Net Income and Gross profit
  • Figure 37. Aspen Technology Inc (United States) Revenue: by Geography 2021
  • Figure 38. Penwest Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 39. Penwest Pharmaceuticals (United States) Revenue: by Geography 2021
  • Figure 40. Orbis Biosciences, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 41. Orbis Biosciences, Inc (United States) Revenue: by Geography 2021
  • Figure 42. Lubrizol Life Science (United States) Revenue, Net Income and Gross profit
  • Figure 43. Lubrizol Life Science (United States) Revenue: by Geography 2021
  • Figure 44. Colorcon (United States) Revenue, Net Income and Gross profit
  • Figure 45. Colorcon (United States) Revenue: by Geography 2021
  • Figure 46. IRISYS, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 47. IRISYS, LLC (United States) Revenue: by Geography 2021
  • Figure 48. Elkem ASA (United States) Revenue, Net Income and Gross profit
  • Figure 49. Elkem ASA (United States) Revenue: by Geography 2021
  • Figure 50. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 51. AstraZeneca (United Kingdom) Revenue: by Geography 2021
  • Figure 52. Global Controlled Release Drug Delivery: by Type USD Million (2022-2027)
  • Figure 53. Global Controlled Release Drug Delivery: by Application USD Million (2022-2027)
  • Figure 54. Global Controlled Release Drug Delivery: by Route of Administration USD Million (2022-2027)
  • Figure 55. Global Controlled Release Drug Delivery: by Technology USD Million (2022-2027)
  • Figure 56. South America Controlled Release Drug Delivery Share (%), by Country
  • Figure 57. Asia Pacific Controlled Release Drug Delivery Share (%), by Country
  • Figure 58. Europe Controlled Release Drug Delivery Share (%), by Country
  • Figure 59. MEA Controlled Release Drug Delivery Share (%), by Country
  • Figure 60. North America Controlled Release Drug Delivery Share (%), by Country
  • Figure 61. Global Controlled Release Drug Delivery: by Type K Tons (2022-2027)
  • Figure 62. Global Controlled Release Drug Delivery: by Application K Tons (2022-2027)
  • Figure 63. Global Controlled Release Drug Delivery: by Route of Administration K Tons (2022-2027)
  • Figure 64. Global Controlled Release Drug Delivery: by Technology K Tons (2022-2027)
  • Figure 65. South America Controlled Release Drug Delivery Share (%), by Country
  • Figure 66. Asia Pacific Controlled Release Drug Delivery Share (%), by Country
  • Figure 67. Europe Controlled Release Drug Delivery Share (%), by Country
  • Figure 68. MEA Controlled Release Drug Delivery Share (%), by Country
  • Figure 69. North America Controlled Release Drug Delivery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Johnson and Johnson (United States)
  • Merck and Co., Inc (United States)
  • Pfizer, Inc. (United States)
  • Corium International, Inc. (Sweden)
  • Aradigm Corporation (Finland)
  • Aspen Technology Inc (United States)
  • Penwest Pharmaceuticals (United States)
  • Orbis Biosciences, Inc (United States)
  • Lubrizol Life Science (United States)
  • Colorcon (United States)
  • IRISYS, LLC (United States)
  • Elkem ASA (United States)
  • AstraZeneca (United Kingdom)
Select User Access Type

Key Highlights of Report


Jun 2023 219 Pages 60 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Controlled Release Drug Delivery Market Quantitative research analysis
Global Controlled Release Drug Delivery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Johnson and Johnson (United States), Merck and Co., Inc (United States), Pfizer, Inc. (United States), Corium International, Inc. (Sweden), Aradigm Corporation (Finland), Aspen Technology Inc (United States), Penwest Pharmaceuticals (United States), Orbis Biosciences, Inc (United States), Lubrizol Life Science (United States), Colorcon (United States), IRISYS, LLC (United States), Elkem ASA (United States) and AstraZeneca (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Pharmaceutical Industry Is Leading Towards Providing Cost Efficient Drug Delivery Systems" is seen as one of major influencing trends for Controlled Release Drug Delivery Market during projected period 2021-2027.
The Controlled Release Drug Delivery market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Controlled Release Drug Delivery Market Report?

Have a Query? Click Here

Other Related Reports

Medical Penicillin Comprehensive Study by Type (Natural Penicillins (Benzylpenicillin, Phenoxymethylpenicillin), Penicillinase Resistant, Extended Spectrum, Anti-Pseudomonal), Application (Respirator...
$ 3750
Antithrombotic Drugs Comprehensive Study by Type (Anti-Coagulants, Anti-Platelet Drugs, Thrombolytic Drugs), Application (Thromboembolic Disease Treatment, Prophylactic Treatment, Blood Clot Preventi...
$ 3750
Pet Pharmaceuticals Comprehensive Study by Type (Pain Medications, Anesthetics, Heartworm Preventatives, Antibiotics, Chemotherapy drugs), Application (Treatment, Prevention), Distribution Chanel (On...
$ 3500
Ophthalmol Drug Comprehensive Study by Type (Antiseptics, Corticosteroids, Anit- Microbial, Fluoroquinolone Antibiotic, Others), Administration (Oral, Intravenous, Parenteral), Indication (Cataract, ...
$ 3450
Chromoendoscopy Agents Comprehensive Study by Type (Absorptive Agent, Contrast Agent, Reactive Agent), Application (Colorectal, Esophageal, Gastric), By End User (Ambulatory Surgical Center, Diagnost...
$ 3350
Crohn Disease Comprehensive Study by Application (Achieving remission (the absence of symptoms), Maintaining remission (prevention of flare-ups), Pediatric Disease), Drug Type (Anti-inflammatory drug...
$ 3750